Wei-Zhong Tang

Dr. Wei-Zhong Tang


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 July 2022 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
JGJiawei Gong
Jiawei Gong
TZTongtong Zhang
Tongtong Zhang
TLTao Luo
Tao Luo
XLXuan Luo
Xuan Luo
FYFei Yan
Fei Yan
JLJiyang Liu
Jiyang Liu

7 January 2021 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
JLJungang Liu
Jungang Liu
XHXiaoliang Huang
Xiaoliang Huang
HLHaizhou Liu
Haizhou Liu
CWChunyin Wei
Chunyin Wei
HRHaiming Ru
Haiming Ru
WTWei-Zhong Tang
Wei-Zhong Tang
Background: KRASgene is the most common type of mutation reported in colorectal cancer (CRC).KRASmutation-mediated regulation of immunophenotype and immune pathways in CRC remains to be elucidated.Methods: 535 CRC patients were used to compare the expression of immune-related genes (IRGs) and the abundance of tumor-infiltrating immune cells (TIICs) in the tumor microenvironment betweenKRAS-mutant andKRASwild-type CRC patients. An independent dataset included 566 cases of CRC and an in-house RNA sequencing dataset were served as validation sets. An in-house dataset consisting of 335 CRC patients were used to analyze systemic immune and inflammatory state in the presence ofKRASmutation. An immue risk (Imm-R) model consist of IRG and TIICs for prognostic prediction inKRAS-mutant CRC patients was established and validated.Results: NF-κB and T-cell receptor signaling pathways were significantly inhibited inKRAS-mutant CRC patients. Regulatory T cells (Tregs) was increased while macrophage M1 and activated CD4 memory T cell was decreased inKRAS-mutant CRC. Prognosis correlated with enhanced Tregs, macrophage M1 and activated CD4 memory T cell and was validated. Serum levels of hypersensitive C-reactive protein (hs-CRP), CRP, and IgM were significantly decreased inKRAS-mutant compared toKRASwild-type CRC patients. An immune risk model composed of VGF, RLN3, CT45A1 and TIICs signature classified CRC patients with distinct clinical outcomes.Conclusions: KRASmutation in CRC was associated with suppressed immune pathways and immune infiltration. The aberrant immune pathways and immune cells help to understand the tumor immune microenvironments inKRAS-mutant CRC patients.

1 January 2020 in International Journal of Biological Sciences
Verified
Journal Article
Open access
SLSiyuan Liang
Siyuan Liang
YMYan Mao
Yan Mao
MLMing Liao
Ming Liao
YXYansong Xu
Yansong Xu
YCYingchun Chen
Yingchun Chen
WTWei-Zhong Tang
Wei-Zhong Tang
Background: The 'adenoma-carcinoma sequence' is a well-recognized model of colorectal cancer (CRC) development. However, the interaction between gut microbiota and genetic variation in the initiation of CRC is not clear. Our study attempts to demonstrate the relationship between gut microbiota and host genetics in patients with intestinal adenomatous polyps.

21 June 2022 in Frontiers in Oncology
Verified
Journal Article
Open access
JLJiansheng Lin
Jiansheng Lin
HZHongwei Zhang
Hongwei Zhang
HYHongping Yu
Hongping Yu
XBXinyu Bi
Xinyu Bi
WZWeilu Zhang
Weilu Zhang
GCGuangwen Cao
Guangwen Cao
Background: The contribution of hepatitis B virus (HBV) and hepatitis C virus (HCV) to primary liver cancer (PLC) and their association with cancer aggressiveness remains uncertain in China, a country with half of global PLC. We aimed to characterize this using data from four representative medical centers.Methods: In total, 15,801 PLC patients were enrolled from the centers distributed in Easter5n, Southern, Northern, and Western China from 2003 to 2020. Of those, 7585 with curative surgery were involved in survival analysis. A nomogram was constructed using preoperative parameters to predict postoperative survival.Results: Hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma, and combined hepatocellular cholangiocarcinoma accounted for 93.0%, 4.3%, and 1.6% in PLC, respectively. The seropositivities of HBV and HCV were 84.4% and 3.2% in HCC, respectively. The seropositivity of anti-HCV antibody was significantly higher in HBV-negative than in HBV-positive HCC patients (13.2% vs. 1.1%). Compared to HCV-positive HCC (HCV-HCC), HBV-positive HCC (HBV-HCC) was associated with 12-year earlier onset, higher proportions of males, high α-fetoprotein, large tumor size, advanced Barcelona Clinic Liver Cancer (BCLC) stage, and vascular tumor thrombus. The proportions of HCC and HBV seropositivity increased, whereas that of anti-HCV decreased, from 2003 to 2020. Postoperative five-year survival rate was 73.5%, 64.1%, 34.9%, and 19.7% in HCC at BCLC stage 0, A, B, and C, respectively. The multivariate Cox regression analysis showed that HBV seropositivity, incomplete tumor capsule, vascular tumor thrombus, tumor diameter (≥3 cm), advanced BCLC stage (B+C), α-fetoprotein (≥20ng/ml), and direct bilirubin (>8µmol/L) contributed independently to shorter overall survival (OS); whereas post-operative radiofrequency ablation and second resection independently improved OS in HCC. HCV-HCC had a more favorable prognosis than did HBV-HCC (Log-rank test, P<0.001). A nomogram composed of age, gender, and the preoperative independent risk factors was accurate in predicting postoperative survival in HCC (C-index: 0.735; 95% confidence interval: 0.727–0.743).Conclusion: HBV contributes to 84.4% of HCC in China, and actively promotes hepatocarcinogenesis and HCC progression. A favorable postoperative survival obtained in patients at the early BCLC stage highlights the importance of screening for early HCC in high-risk populations. Our preoperative prognosis prediction model is important in clinical decision-making.

8 June 2023 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
JLJungang Liu
Jungang Liu
XHXiaoliang Huang
Xiaoliang Huang
CCChuanbin Chen
Chuanbin Chen
ZWZhen Wang
Zhen Wang
ZHZigui Huang
Zigui Huang
WTWei-Zhong Tang
Wei-Zhong Tang
Objective: The relationship between intestinal microbiome and colorectal cancer (CRC) progression is unclear. This study aims to identify the intestinal microbiome associated with CRC progression and construct predictive labels to support the accurate assessment and treatment of CRC. Method: The 192 patients included in the study were divided into stage I-II and stage III-IV CRC patients according to the pathological stages, and preoperative stools were collected from both groups for 16S rDNA sequencing of the intestinal microbiota. Pearson correlation and Spearman correlation coefficient analysis were used to analyze the differential intestinal microbiome and the correlation with tumor microenvironment and to predict the functional pathway. XGBoost model (XGB) and Random Forest model (RF) were used to construct the microbiome-based signature. The total RNA extraction from 17 CRC tumor simples was used for transcriptome sequencing. Result: The Simpson index of intestinal microbiome in stage III-IV CRC were significantly lower than those in stage I-II CRC. Proteus, Parabacteroides, Alistipes and Ruminococcus etc. are significantly enriched genus in feces of CRC patients with stage III-IV. ko00514: Other types of O − glycan biosynthesis pathway is relevant with CRC progression. Alistipes indistinctus was positively correlated with mast cells, immune activators IL-6 and IL6R, and GOBP_PROTEIN_FOLDING_IN_ENDOPLASMIC_RETICULUM dominantly. The Random Forest (RF) model and eXtreme Gradient Boosting (XGBoost) model constructed with 42 CRC progression-associated differential bacteria were effective in distinguishing CRC patients between stage I-II and stage III-IV. Conclusions: The abundance and diversity of intestinal microbiome may increase gradually with the occurrence and progression of CRC. Elevated fetal abundance of Proteus, Parabacteroides, Alistipes and Ruminococcus may contribute to CRC progression. Enhanced synthesis of O − glycans may result in CRC progression. Alistipes indistinctus may play a facilitated role in mast cell maturation by boosting IL-6 production. Alistipes indistinctus may work in the correct folding of endoplasmic reticulum proteins in CRC, reducing ER stress and prompting the survival and deterioration of CRC, which may owe to the enhanced PERK expression and activation of downstream UPR by Alistipes indistinctus. The CRC progression-associated differential intestinal microbiome identified in our study can be served as potential microbial markers for CRC staging prediction.

1 May 2021 in Journal of Hazardous Materials
Verified
Journal Article
Closed access
FYFei Yan
Fei Yan
TLTao Luo
Tao Luo
QJQifan Jin
Qifan Jin
HZHuaxu Zhou
Huaxu Zhou
ASAjabkhan Sailjoi
Ajabkhan Sailjoi
WTWei-Zhong Tang
Wei-Zhong Tang